HitGen Inc
SSE:688222

Watchlist Manager
HitGen Inc Logo
HitGen Inc
SSE:688222
Watchlist
Price: 12.07 CNY -7.08% Market Closed
Market Cap: 4.8B CNY
Have any thoughts about
HitGen Inc?
Write Note

HitGen Inc
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

HitGen Inc
Other Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
HitGen Inc
SSE:688222
Other Equity
ÂĄ5.1m
CAGR 3-Years
36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Other Equity
ÂĄ129.4m
CAGR 3-Years
N/A
CAGR 5-Years
4%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Other Equity
-ÂĄ42.3m
CAGR 3-Years
N/A
CAGR 5-Years
-31%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Other Equity
-ÂĄ1.2B
CAGR 3-Years
-114%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Other Equity
ÂĄ84.4m
CAGR 3-Years
N/A
CAGR 5-Years
33%
CAGR 10-Years
N/A
W
WuXi XDC Cayman Inc
HKEX:2268
Other Equity
ÂĄ1.1m
CAGR 3-Years
-13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

HitGen Inc
Glance View

Market Cap
4.8B CNY
Industry
Life Sciences Tools & Services

HitGen, Inc. engages in the provision deoxyribonucleic acid encoded compound library (DEL) for research and development of seed and lead compounds. The company is headquartered in Chengdu, Sichuan and currently employs 508 full-time employees. The company went IPO on 2020-04-16. The firm focuses on the research and creation of deoxyribonucleic acid encoded compound library (DEL) technology, research and development of hit compounds and lead compounds. The firm mainly provides DEL screening services, DEL library customization services, chemical synthesis services and transfer of new drug research and development projects. The firm conducts its businesses within the domestic market and to overseas markets.

Intrinsic Value
7.23 CNY
Overvaluation 40%
Intrinsic Value
Price

See Also

What is HitGen Inc's Other Equity?
Other Equity
5.1m CNY

Based on the financial report for Dec 31, 2023, HitGen Inc's Other Equity amounts to 5.1m CNY.

What is HitGen Inc's Other Equity growth rate?
Other Equity CAGR 3Y
36%

The average annual Other Equity growth rates for HitGen Inc have been 36% over the past three years .

Back to Top